For: | Liu MT, Maroney ME, Hermes-DeSantis ER. Levomilnacipran and vortioxetine: Review of new pharmacotherapies for major depressive disorder. World J Pharmacol 2015; 4(1): 17-30 [DOI: 10.5497/wjp.v4.i1.17] |
---|---|
URL: | https://www.wjgnet.com/2220-3192/full/v4/i1/17.htm |
Number | Citing Articles |
1 |
Masoud Behzadifar, Hamidreza Dehghan, Korush Saki, Meysam Behzadifar, Abouzar Keshavarzi, Maryam Saran, Ali Akbari Sari. Evaluation Efficacy and Safety of Vortioxetine 20 mg/d versus Placebo for Treatment Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pharmacology & Pharmacy 2015; 6(04): 221 doi: 10.4236/pp.2015.64024
|
2 |
Masoud Behzadifar, Abouzar Keshavarzi, Abed Tofighian, Mohammad Rastian, Mohammad Zobidi, Ali Akbari Sari. Efficacy and Safety of Vortioxetine and Duloxetine 60 mg Compared Placebo for the Treatment of Major Depressive Disorder: A Systematic Review and Meta-Analysis. Journal of Behavioral and Brain Science 2015; 5(10): 430 doi: 10.4236/jbbs.2015.510041
|